Related Experiment Video
Updated: Jul 18, 2026

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
Published on: July 29, 2007
Case Report: Stem cell therapy in amyotrophic lateral sclerosis.
Ala'a A Hassan1, Jeananne Elkins2, Hisham Y Hassan3
1Physiotherapy and Rehabilitation Department, Bahrain Defence Force Hospital, Riffa, Bahrain.
Stem cell therapy (SCT) did not benefit this amyotrophic lateral sclerosis (ALS) patient, who rapidly declined post-procedure. The case highlights ethical concerns regarding marketing unproven ALS treatments.
Area of Science:
- Neuroscience
- Regenerative Medicine
Background:
- Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease affecting motor neurons.
- Rehabilitation aids ALS patients' quality of life but does not halt disease progression.
- Current evidence shows no benefit from stem cell therapy (SCT) for ALS.
Observation:
- This case report details an ALS patient who underwent SCT.
- The patient experienced rapid deterioration following the SCT procedure.
Findings:
- The cause of rapid deterioration post-SCT in this ALS case remains undetermined.
- Ethical considerations surrounding marketing of unproven therapies to desperate patients are discussed.
Implications:
- Patient education and open communication are crucial for managing expectations with unconventional ALS treatments.
- Multidisciplinary care, symptom management, and end-of-life planning enhance the quality of life for ALS patients.
More Related Videos
10:49Intraspinal Cell Transplantation for Targeting Cervical Ventral Horn in Amyotrophic Lateral Sclerosis and Traumatic Spinal Cord Injury
Published on: September 18, 2011
12:35Clinical Testing and Spinal Cord Removal in a Mouse Model for Amyotrophic Lateral Sclerosis ALS
Published on: March 17, 2012
Related Concept Videos
Satellite Stem Cells and Muscular Dystrophy
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
iPS Cell Differentiation